UNAIDS [Internet]. [cited 2023 Sep 16]. Available from: https://www.unaids.org/en

Egger M, Hirschel B, Francioli P, Sudre P, Wirz M, Flepp M, et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. BMJ. 1997;315:1194–9.

Article  PubMed  PubMed Central  Google Scholar 

Mansky LM. Retrovirus mutation rates and their role in genetic variation. J Gen Virol. 1998;79:1337–45.

Article  PubMed  Google Scholar 

Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science. 1995;267:483–9.

Article  PubMed  Google Scholar 

Ghimire D, Rai M, Gaur R. Novel host restriction factors implicated in HIV-1 replication. J Gen Virol. 2018;99:435–46.

Article  PubMed  Google Scholar 

Clavel F. HIV Drug Resistance. The New England Journal of Medicine. 2004.

Kemp SA, Charles OJ, Derache A, Smidt W, Martin DP, Iwuji C, et al. HIV-1 evolutionary dynamics under nonsuppressive antiretroviral therapy. Mbio. 2022;13:e0026922.

Article  PubMed  Google Scholar 

Pandit A, de Boer RJ. Reliable reconstruction of HIV-1 whole genome haplotypes reveals clonal interference and genetic hitchhiking among immune escape variants. Retrovirology. 2014;11:56.

Article  PubMed  PubMed Central  Google Scholar 

Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Sci (n Y NY). 1995;267:483–9.

Article  Google Scholar 

Kearney M, Palmer S, Maldarelli F, Shao W, Polis MA, Mican J, et al. Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase. Aids. 2008;22:497–501.

Article  PubMed  Google Scholar 

Palmer S, Boltz V, Maldarelli F, Kearney M, Halvas EK, Rock D, et al. Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy. AIDS (lond Engl). 2006;20:701–10.

Article  Google Scholar 

Paredes R, Marconi VC, Campbell TB, Kuritzkes DR. Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and Env resistance mutations. J Virol Methods. 2007;146:136–46.

Article  PubMed  PubMed Central  Google Scholar 

Simen BB, Simons JF, Hullsiek KH, Novak RM, MacArthur RD, Baxter JD, et al. Low-Abundance Drug-Resistant viral variants in chronically HIV-Infected, antiretroviral treatment–Naive patients significantly impact treatment outcomes. J Infect Dis. 2009;199:693–701.

Article  PubMed  Google Scholar 

Li JZ, Low-Frequency. HIV-1 drug resistance mutations and risk of NNRTI-Based antiretroviral treatment failure: A systematic review and pooled analysis. JAMA. 2011;305:1327.

Article  PubMed  PubMed Central  Google Scholar 

Consolidated. guidelines on HIV prevention, testing, treatment, service delivery and monitoring: Recommendations for a public health approach [Internet]. [cited 2024 May 7]. Available from: https://www.who.int/publications-detail-redirect/9789240031593

Palmer S, Kearney M, Maldarelli F, Halvas EK, Bixby CJ, Bazmi H, et al. Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in Treatment-Experienced patients are missed by standard genotype analysis. J Clin Microbiol. 2005;43:406–13.

Article  PubMed  PubMed Central  Google Scholar 

Casadellà M, Manzardo C, Noguera-Julian M, Ferrer E, Domingo P, Pérez-Álvarez S, et al. Clinical value of ultradeep HIV-1 genotyping and tropism testing in late presenters with advanced disease. AIDS (Lond Engl). 2015;29:1493–504.

Article  Google Scholar 

Metzner KJ, Giulieri SG, Knoepfel SA, Rauch P, Burgisser P, Yerly S, et al. Minority quasispecies of Drug-Resistant HIV‐1 that lead to early therapy failure in Treatment‐Naive and ‐Adherent patients. Clin Infect Dis. 2009;48:239–47.

Article  PubMed  Google Scholar 

Li JZ, Paredes R, Ribaudo HJ, Svarovskaia ES, Metzner KJ, Kozal MJ, et al. Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: A systematic review and pooled analysis. JAMA. 2011;305:1327–35.

Article  PubMed  PubMed Central  Google Scholar 

Zhang R, Jiang Q, Zhuang Z, Zeng H, Li Y. A bibliometric analysis of drug resistance in immunotherapy for breast cancer: trends, themes, and research focus. Front Immunol. 2024;15:1452303.

Article  PubMed  PubMed Central  Google Scholar 

Tang F, Zhao F, Jiang Y, Zhang T, Wang B. Global hotspots and trends in diabetic peripheral neuropathy research from 2011 to 2023. Med (Baltim). 2024;103:e39295.

Article  Google Scholar 

Deng J, Qin Y. Current status, hotspots, and prospects of artificial intelligence in ophthalmology: A bibliometric analysis (2003–2023). Ophthalmic Epidemiol. 2024;1–14.

Marzi G, Caputo A, Garces E, Dabić M. A three decade mixed-method bibliometric investigation of the IEEE transactions on engineering management. IEEE Trans Eng Manage. 2020;67:4–17.

Article  Google Scholar 

Wu H, Li Y, Tong L, Wang Y, Sun Z. Worldwide research tendency and hotspots on hip fracture: A 20-year bibliometric analysis. Arch Osteoporos. 2021;16:73.

Article  PubMed  Google Scholar 

Yang Y, Reniers G, Chen G, Goerlandt F. A bibliometric review of laboratory safety in universities. Saf Sci. 2019;120:14–24.

Article  Google Scholar 

Aria M, Cuccurullo C. bibliometrix: an R-tool for comprehensive science mapping analysis. J Informetr. 2017;11:959–75.

Article  Google Scholar 

Chiari W, Damayanti R, Harapan H, Puspita K, Saiful S, Rahmi R, et al. Trend of polymer research related to COVID-19 pandemic: bibliometric analysis. Polymers. 2022;14:3297.

Article  PubMed  PubMed Central  Google Scholar 

Casadellà M, Paredes R. Deep sequencing for HIV-1 clinical management. Virus Res. 2017;239:69–81.

Article  PubMed  Google Scholar 

Milne RS, Silverman RA, Beck IA, Mckernan-Mullin J, Deng W, Sibley TR, et al. Minority and majority pretreatment HIV-1 drug resistance associated with failure of first-line nonnucleoside reverse-transcriptase inhibitor antiretroviral therapy in Kenyan women. AIDS. 2019;33:941–51.

Article  PubMed  Google Scholar 

Novitsky V, Nyandiko W, Vreeman R, DeLong AK, Manne A, Scanlon M, et al. Added value of next generation over Sanger sequencing in Kenyan youth with extensive HIV-1 drug resistance. Microbiol Spectr. 2022;10:e0345422.

Article  PubMed  Google Scholar 

Wang C, Mitsuya Y, Gharizadeh B, Ronaghi M, Shafer RW. Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. Genome Res. 2007;17:1195–201.

Article  PubMed  PubMed Central  Google Scholar 

Nishizawa M, Hattori J, Shiino T, Matano T, Heneine W, Johnson JA, et al. Highly-sensitive allele-specific PCR testing identifies a greater prevalence of transmitted HIV drug resistance in Japan. PLoS ONE. 2013;8:e83150.

Article  PubMed  PubMed Central  Google Scholar 

Delobel P, Saliou A, Nicot F, Dubois M, Trancart S, Tangre P, et al. Minor HIV-1 variants with the K103N resistance mutation during intermittent efavirenz-containing antiretroviral therapy and virological failure. PLoS ONE. 2011;6:e21655.

Article  PubMed  PubMed Central  Google Scholar 

Gianella S, Richman DD. Minority variants of drug-resistant HIV. J Infect Dis. 2010;202:657.

Article  PubMed  Google Scholar 

Sili U, Aksu B, Tekin A, Hasdemir U, Soyletir G, Korten V. Assessment of transmitted HIV-1 drug resistance mutations using ultra- deep pyrosequencing in a Turkish cohort. Curr HIV Res. 16:216–21.

Alteri C, Santoro MM, Abbate I, Rozera G, Bruselles A, Bartolini B, et al. Sentinel mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing. J Antimicrob Chemother. 2011;66:2615–23.

Article  PubMed  Google Scholar 

Pingen M, van der Ende M, Wensing A, el Barzouhi A, Simen B, Schutten M, et al. Deep sequencing does not reveal additional transmitted mutations in patients diagnosed with HIV-1 variants with single nucleoside reverse transcriptase inhibitor resistance mutations. HIV Med. 2013;14:176–81.

Article  PubMed  Google Scholar 

Alidjinou EK, Deldalle J, Hallaert C, Robineau O, Ajana F, Choisy P, et al. RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients. J Antimicrob Chemother. 2017;72:2823–30.

Article  PubMed  Google Scholar 

Nicot F, Jeanne N, Raymond S, Delfour O, Carcenac R, Lefebvre C, et al. Performance comparison of deep sequencing platforms for detecting HIV-1 variants in the pol gene. J Med Virol. 2018;90:1486–92.

Article